To ensure access to prescription medications

The bill regulates pharmacy benefits managers (PBMs) by setting rules for listing drug costs on a maximum allowable cost list. It ensures drugs on such lists meet specific standards and provides a process for pharmacies to challenge these costs. The bill requires updated lists and cost adjustments when challenges are successful. It protects pharmacies from retroactive discounts and ensures transparent pricing information is shared appropriately. Additionally, it mandates that MassHealth organizations reimburse pharmacies at standard rates and allows pharmacies to share certain information with patients.

Supporters would argue this bill promotes fairness by ensuring pharmacies are reimbursed adequately, which helps maintain access to essential medications. It increases transparency and supports pharmacies with a fair process to contest drug pricing. The bill also aims to protect consumers by allowing pharmacies to share cost-effective drug alternatives and benefit-related information, fostering informed healthcare choices.

Critics might claim the bill imposes regulatory burdens on pharmacy benefits managers, potentially leading to increased operational costs. They could argue these regulations may eventually be passed to consumers through higher healthcare premiums. Concerns may also be raised about the limitation of competition and innovation in drug pricing strategies due to stringent pricing rules.